Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

281 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis.
De Benedetti F, Brunner HI, Ruperto N, Kenwright A, Wright S, Calvo I, Cuttica R, Ravelli A, Schneider R, Woo P, Wouters C, Xavier R, Zemel L, Baildam E, Burgos-Vargas R, Dolezalova P, Garay SM, Merino R, Joos R, Grom A, Wulffraat N, Zuber Z, Zulian F, Lovell D, Martini A; PRINTO; PRCSG. De Benedetti F, et al. N Engl J Med. 2012 Dec 20;367(25):2385-95. doi: 10.1056/NEJMoa1112802. N Engl J Med. 2012. PMID: 23252525 Free article. Clinical Trial.
Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritis.
Brunner HI, Ruperto N, Ramanan AV, Horneff G, Minden K, Calvo Penades I, Alexeeva E, Cleary G, Stern SM, Kone-Paut I, Maldonado Velázquez MDR, Rabinovich CE, Remesal A, Silva CA, Nikishina I, Zucchetto M, Brockwell L, Gordon O, Nagel S, De Benedetti F; PRINTO and PRCSG investigators. Brunner HI, et al. Among authors: de benedetti f. Rheumatology (Oxford). 2024 Mar 29:keae180. doi: 10.1093/rheumatology/keae180. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38552315
CAR T-Cell Therapy in Autoimmune Disease.
De Benedetti F, Diomedi Camassei F, Locatelli F. De Benedetti F, et al. N Engl J Med. 2024 May 2;390(17):1629. doi: 10.1056/NEJMc2403705. N Engl J Med. 2024. PMID: 38692298 No abstract available.
Definition and validation of serum biomarkers for optimal differentiation of hyperferritinaemic cytokine storm conditions in children: a retrospective cohort study.
Kessel C, Fall N, Grom A, de Jager W, Vastert S, Strippoli R, Bracaglia C, Sundberg E, Horne A, Ehl S, Ammann S, Wouters C, Lehmberg K, De Benedetti F, Park C, Hinze C, Wittkowski H, Kessel K, Beutel K, Foell D, Holzinger D. Kessel C, et al. Among authors: de benedetti f, de jager w. Lancet Rheumatol. 2021 Aug;3(8):e563-e573. doi: 10.1016/S2665-9913(21)00115-6. Epub 2021 Jun 8. Lancet Rheumatol. 2021. PMID: 38287622
Microbiota transplant to control inflammation in a patient with NLRC4 gain-of-function-induced disease.
Bracaglia C, Marucci G, Del Chierico F, Russo A, Pardeo M, Pires Marafon D, Quagliariello A, Caiello I, Rea F, Fingerhutova S, Insalaco A, Prencipe G, Dolezalova P, De Benedetti F, Putignani L. Bracaglia C, et al. Among authors: de benedetti f. J Allergy Clin Immunol. 2023 Jul;152(1):302-303. doi: 10.1016/j.jaci.2023.03.031. Epub 2023 May 10. J Allergy Clin Immunol. 2023. PMID: 37178069 No abstract available.
The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS).
Shakoory B, Geerlinks A, Wilejto M, Kernan K, Hines M, Romano M, Piskin D, Ravelli A, Sinha R, Aletaha D, Allen C, Bassiri H, Behrens EM, Carcillo J, Carl L, Chatham W, Cohen JI, Cron RQ, Drewniak E, Grom AA, Henderson LA, Horne A, Jordan MB, Nichols KE, Schulert G, Vastert S, Demirkaya E, Goldbach-Mansky R, de Benedetti F, Marsh RA, Canna SW; HLH/MAS task force. Shakoory B, et al. Among authors: de benedetti f. Ann Rheum Dis. 2023 Oct;82(10):1271-1285. doi: 10.1136/ard-2023-224123. Epub 2023 Jul 24. Ann Rheum Dis. 2023. PMID: 37487610 Free PMC article.
281 results